Scientific Associate II-III #2

University Health Network (UHN) is looking for an experienced professional to fill the key role of Scientific Associate II-III in our Experimental Therapeutics -Infection and Immunity department.

Transforming lives and communities through excellence in care, discovery and learning.

The University Health Network, where “above all else the needs of patients come first”, encompasses Toronto Rehabilitation Institute, Toronto General Hospital, Toronto Western Hospital, Princess Margaret Cancer Centre and the Michener Institute of Education at UHN. The breadth of research, the complexity of the cases treated, and the magnitude of its educational enterprise has made UHN a national and international resource for patient care, research and education. With a long tradition of groundbreaking firsts and a purpose of “Transforming lives and communities through excellence in care, discovery and learning”, the University Health Network (UHN), Canada’s largest research teaching hospital, brings together over 16,000 employees, more than 1,200 physicians, 8,000+ students, and many volunteers. UHN is a caring, creative place where amazing people are amazing the world.

University Health Network (UHN) is a research hospital affiliated with the University of Toronto and a member of the Toronto Academic Health Science Network. The scope of research and complexity of cases at UHN have made it a national and international source for discovery, education and patient care. Research across UHN’s five research institutes spans the full spectrum of diseases and disciplines, including cancer, cardiovascular sciences, transplantation, neural and sensory sciences, musculoskeletal health, rehabilitation sciences, and community and population health. Find out about our purpose, values and principles here.

More than 250 million people are chronically infected with Hepatitis B virus (HBV) with no effective cure. The lab is part of the Toronto Centre for Liver Disease, one of the largest liver clinics in North America, with an active clinical trial research program testing novel hepatitis B therapies in Phase 2 studies. New studies are incorporating longitudinal liver sampling with single-cell RNA sequencing (scRNAseq) to better understand the intrahepatic immune response to novel treatments in the context of viral control and liver inflammation.

We are part of the Immunology Department at the University of Toronto comprising of over 70 faculty members. This integration provides incredible access to knowledge, expertise, seminars and collaboration in one of the most liveable cities in the world.

We are looking for a bioinformatics postdoctoral fellow with demonstrated experience single-cell RNA sequencing analysis. The anticipation is that this qualified person will be able to work with scRNAseq datasets with cell numbers >150,000 cells and be able to incorporate the latest analysis tools.

This is an opportunity to work with state-of-the-art data in the context of novel drugs in early stage clinical trials. The position will involve industry collaboration with the expectation of academic publication. There will also be internal opportunities for collaboration in our basic research projects focused HBV pathogenesis using similar samples. The successful applicant will be expected to bring novel ideas and approaches to the research program and contribute to the scientific development of the analysis plan and manuscript preparation.

If you are interested in making your contribution at UHN, please apply on-line. You will be asked to copy and paste as well as attach your resume and covering letter. You will also be required to complete a series of initial screening questions.